A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cells 

Anthony S Don, Oliver Kisker, Pierre Dilda, Neil Donoghue, Xueyun Zhao, Stephanie Decollogne, Belinda Creighton, Evelyn Flynn, Judah Folkman, Philip J Hogg 

Cancer Cell Volume 3, Issue 5, Pages 497-509 (May 2003)

DOI: 10.1016/S1535-6108(03)00109-0

Figure 1

Cancer Cell 2003 3, 497-509DOI: (10.1016/S1535-6108(03)00109-0)

Figure 2

Cancer Cell 2003 3, 497-509DOI: (10.1016/S1535-6108(03)00109-0)

Figure 3

Cancer Cell 2003 3, 497-509DOI: (10.1016/S1535-6108(03)00109-0)

Figure 4

Cancer Cell 2003 3, 497-509DOI: (10.1016/S1535-6108(03)00109-0)

Figure 5

Cancer Cell 2003 3, 497-509DOI: (10.1016/S1535-6108(03)00109-0)

Figure 6

Cancer Cell 2003 3, 497-509DOI: (10.1016/S1535-6108(03)00109-0)

Figure 7

Cancer Cell 2003 3, 497-509DOI: (10.1016/S1535-6108(03)00109-0)